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Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis Rheumatoid arthritis (RA) is an autoimmune disease with a prevalence of 1%. The contribution of genetic factors on RA susceptibility is shown by twin and population studies. The concordance rates on monozygotic twins ranges from 12% to 15% while in dizygotic twins it is 3% to 4%. 1 The major genetic component influencing RA susceptibility is a group of alleles in the DRB1 gene sharing a sequence motif, namely the ''shared epitope'' (SE). Recent evidence has also implicated the common allele of the R620W variant in the haematopoietic-specific protein tyrosine kinase protein tyrosine phosphatase non-receptor type 22 (PTPN22) with susceptibility to several autoimmune diseases including RA. 2 The recent genome-wide association study conducted by the Wellcome Trust Case Control Consortium (WTCCC) screened 1860 RA cases and 2938 healthy controls strongly replicated the association of the PTPN22 with RA susceptibility (p,0.001). 3 Nine additional new loci of particular interest were also identified with significant (,0.001) p values, such as variants close to the a and b chains of the IL2R as well as genes involved in the tumour necrosis factor (TNF) pathway and T cell regulation. 3 A replication study of these 9 loci was also performed in an independent cohort of 5063 RA cases and 3849 healthy controls collected from 6 different centres and confirmed the association of rs6920220, located on 6q23 between OLIG3 and TNFAIP3, with increased risk of anti-cyclic citrullinated peptide (CCP)-positive RA as well as the nominal association of the IL2RB gene. 4 TNF receptor-associated factor 1 (TRAF1) and complement component 5 (C5) loci have also emerged as candidate regions by a genome-wide association study and a candidate gene approach study. 56 The identification of RA susceptibility genes is complicated by a number of factors including genetic and disease heterogeneity, gene-gene and gene-environment interactions. Epistasis is defined as a gene-gene interaction in which the genotype at one locus affects the phenotypic expression of the genotype at another locus. A gene with a weak effect on overall disease risk may be important in combination with other genes. Although the extent of epistasis in autoimmune diseases is still unclear, it is reasonable to postulate that such interactions may be a consequence of functional polymorphisms in genes involved in pathways that are implicated in the disease process.
In RA, evidence of interactions comes from linkage and association studies. The first European genome scan provided evidence of RA linkage on chromosome 3 that was stronger in human leukocyte antigen (HLA)-identical sibpairs, suggesting possible interactions between the HLA-DRB1 locus and a region on chromosome 3. 7 The second European genome scan demonstrated RA linkage to the interleukin 1 (IL1) locus that was restricted to HLA-identical sibpairs suggesting that genes of the IL1 cluster may play an additional role only in the presence of RA-related HLA alleles. 8 More recently a gene interaction was detected between PTPN22 R620W and HLA-DRB1 SE alleles, supporting the view that genes with a moderate risk can exert a stronger effect in combination with other risk loci. 9 Recently, selenoprotein S (SELS) has been identified as an important regulator of IL1, TNF and IL6 production with plasma levels of these proteins correlating with functional promoter single nucleotide polymorphisms (SNPs) in SELS. 10 This gene is involved in the stress response within the endoplasmic reticulum (ER) and inflammation. We hypothesised that variants in SELS could influence RA susceptibility and may interact with functional SNPs in the genes for IL1, IL6 and TNF that have been previously associated with RA.
METHODS

Study populations
A total of 988 Caucasians (healthy unrelated individuals) and 965 individuals with RA participated in this study and have been described previously. 11 All patients fulfilled the American College of Rheumatology (ACR) criteria and had a minimum disease duration of 3 years. The South Sheffield Research Ethics Committee approved this study and informed consent was obtained from all participants.
SNP genotyping
Blood samples were collected in EDTA anticoagulated tubes and DNA was extracted using standard methods. TaqMan genotyping assays were designed for functional SNPs in IL1b, IL6, TNF and SELS as previously described (table 1) . 12 Thermal cycling was performed as follows; after an initial denaturation and enzyme activation of 10 min at 95uC, samples were subjected to 40 cycles of 15s at 95uC for denaturation and 60s at 60uC for annealing/extension. We included multiple positive and negative controls in all genotyping plates and repeated 10% of our samples to minimise genotyping errors. Thermal cycling in 384-well plates was performed on a PTC-225 DNA engine Tetrad (MJ Research, San Francisco, California, USA) and genotypes were determined using an ABI Prism 7900HT (PE Biosystems, Foster City, California, USA).
Statistical analysis
Deviation from Hardy-Weinberg equilibrium (HWE) was tested for each SNP in cases and controls separately using a x 2 test with a threshold of p,0.05. The odds ratios (ORs) were calculated with asymptotic 95% confidence intervals (CIs). The mode of inheritance at each locus was determined by the ORs for RA in the three genotype groups.
Gene-gene interactions are often measured as departure from an additive or multiplicative genetic model by, for example, adding a product term between two risk factors in a logistic regression model (statistical interaction), however this method which treats interaction as a residual term in a regression model has no clear biological interpretation. To study gene-gene interactions in addition to the MantelHaenszel (M-H) test we have used a recently described test for interactions between two unlinked loci. This model is based on the assumption that two interacting loci will create linkage disequilibrium (LD) even if these loci are unlinked, the level of which depends on the extent of the interaction. This definition describes the dependence of penetrance for a twoloci haplotype where the penetrance of one locus depends on the genotypes at another locus. 13 The LD-based statistic provides a clearer biological interpretation of epistasis and also an increased power to detect gene-gene interactions under several plausible models of interactions.
Therefore we first stratified study subjects according to IL1 genotypes. Differences in odds ratios of RA (comparing two SELS genotype groups) in the different IL1 genotype groups were determined using the M-H test. In each pairwise test of statistical interaction, the mode of inheritance considered at each locus was that used for the main effects. An alternative method based on measuring the departure from independence of penetrances in two unlinked loci (an LD-based statistic) was also performed. A total of 7 tests for main effects and 21 tests for gene-gene interactions were performed (total of 28 tests). Applying a Bonferroni correction to this number of tests would require a p value less than 0.002 to ensure a conventional type 1 error rate of 5%. The Bonferroni correction however assumes independent tests and is conservative for correlated tests, as the tests in this study are. All p values given in the text are unadjusted and should be judged against the adjusted cut-off of 0.002, bearing in mind that it is a conservative threshold. All statistical analyses were carried out using STATA statistical software (V 9.1, STATA, College Station, Texas, USA).
RESULTS
Genotype and allele distributions
Baseline characteristics of the study populations are summarised elsewhere. 12 Allele and genotype frequencies for all SNPs were in HWE for RA cases and controls. Table 2 shows the genotype frequencies of each SNP in healthy controls and RA cases. A marginal association was detected between IL1b 2511 and RA susceptibility. The 2511AA genotype was under-represented in RA cases compared to healthy controls (OR 0.7, 95% CI 0.5 to 1.0, p = 0.04). Genotypes frequencies were not significantly different for any other variant.
Interaction between IL1b 2511 and SELS 2105
The genotype frequencies for different combinations of IL1b 2511 and SELS 2105 for RA cases and controls are shown in table 3. The presence of a significant interaction was detected using a stratified analysis (M-H test). The OR comparing individuals with the AA/GA genotype to the GG genotype at the SELS 2105 locus in participants who were GG/AG at the IL1b 2511 locus was 0.9 (95% CI 0.7 to 1.1, p = 0.3). In contrast, the presence of at least one copy of the A allele at the SELS 2105 locus (compared to no copies) was associated with an increased risk of RA in subjects who were AA at the IL1b 2511 locus (OR 2.3, 95% CI 1.2 to 4.5, p = 0.007) (table 2). Applying a M-H test of homogeneity of odds ratios suggests that the risk of RA to carriers of the AA/GA genotype compared to the GG genotype at the SELS 2105 locus depends upon their genotype at the IL1b 2511 locus (p = 0.004). While this falls just short of the Bonferroni threshold it is clearly suggestive of a statistical interaction. The LD test statistic yielded stronger, highly significant evidence of a gene-gene interaction between the SELS 2105 and IL1b 2511 loci (p = ,0.001). This considerably exceeds the Bonferroni threshold and together with the M-H analysis provides compelling evidence for a statistical interaction between the SELS 2105 and IL1b 2511 loci in RA. No interaction was detected between SELS 2105 and Extended report the other cytokine SNPs (p = 0.6 for IL62174; p = 0.2 for IL1+3954; p = 0.2; for IL1+4845; p = 0.9; p = 0.6 for TNF308 by M-H test). Subjects were stratified according to the IL1b 2511 genotype and odds ratios for the SELS 2105 gene were calculated in both strata separately. The genetic models used were those previously assigned to each polymorphism and the M-H test was used.
DISCUSSION
In this study we report strong statistical evidence of an interaction between two functional polymorphisms in the IL1b and SELS genes with increased risk of developing RA. There is a large body of evidence implicating IL1 in RA; it is found at high levels in serum and synovial fluid of patients with RA and evidence has shown that, together with TNFa,i t upregulates the expression of matrix metalloproteinases (MMPs) and cell adhesion molecules (CAMs) that are important in bone cartilage and bone resorption.
14 Deletion of the IL1 receptor antagonist gene in Balb/C mice results in an inflammatory polyarthritis. 15 A number of polymorphisms in the IL1 cluster have been extensively associated with inflammatory conditions. The IL1b 2511 polymorphism has been shown to result in loss of a putative activating protein 2 (AP-2) binding site, suggesting its functional importance. 16 Furthermore a haplotype consisting of 2511T and the 231C has been associated with a twofold to threefold increase in LPSinduced IL1b protein production. 16 The SELS 2105 variant is located within a putative endoplasmic reticulum (ER) stress response element (ERSE) and the A allele is associated with impaired SELS expression, leading to increased production of proinflammatory mediators. 10 SELS is a gene involved in ER stress response. It encodes a membrane protein that removes misfolded proteins from the ER to the cytosol and prevents stress responses that lead to activation of the inflammatory cascade. 10 Genetic variation of SELS has been associated with circulating levels of the proinflammatory cytokines IL1b, IL6 and TNF. The promoter variant (2105G.A) significantly impairs SELS expression resulting in increased cytokine production and differential ER stress response, suggesting it to be a strong candidate in the pathogenesis of common inflammatory diseases. 10 However we did not detect a significant association of SELS promoter variants with susceptibility to RA.
As genetic variation of SELS influences circulating levels of proinflammatory cytokines, the presence of epistasis with functional cytokine variants was investigated. Using stratification and LD-based methods significant interaction was observed between the IL1b 2511 and SELS 2105 loci, with the latter method detecting much stronger evidence of epistasis. This may be due to the greater statistical power of the LD-based test statistic compared to the M-H test statistic. The LD-based statistic has been shown to have greater power than logistic regression under several plausible models of epistasis and so it is reasonable to expect that it would also have greater power than the M-H test statistic. Of course other functional genetic variants in high LD with either SNP may be the causative polymorphisms that contribute to increased disease susceptibility. Our data clearly demonstrate that these two genes interactively increase the risk of developing RA. Given the observation of Curran et al and the role of IL1 in RA the increased frequency of the 2105A and 2511A alleles is expected in RA cases and is in line with previous findings.
Our data suggest that the A allele at the SELS 2105 locus is a new candidate for RA pathogenesis in individuals who are homozygous for the rare allele at the IL1b 2511 locus. Although our results are based on small numbers, they confirm the importance of epistatic interactions in the pathogenesis of complex diseases and support the hypothesis that polymorphisms in genes with either moderate or no main effects can have 
